• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    39.66 Up 0.52(1.33%) Dec 26, 4:00PM EST
    |After Hours : 39.66 Up 0.00 (0.01%) Dec 26, 4:44PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 336,430   305,814   292,237  
    Cost of Revenue66,643  57,641  66,567  
    Gross Profit 269,787   248,173   225,670  
    Operating Expenses
    Research Development53,877  53,881  42,108  
    Selling General and Administrative185,545  168,690  148,508  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 30,365   25,602   35,054  
    Income from Continuing Operations
    Total Other Income/Expenses Net668  546  534  
    Earnings Before Interest And Taxes31,033  26,148  35,588  
    Interest Expense2,170  1,880  3,570  
    Income Before Tax28,863  24,268  32,018  
    Income Tax Expense12,422  (130,690)1,413  
    Minority Interest -   -   -  
    Net Income From Continuing Ops16,441  154,958  30,605  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 16,441   154,958   30,605  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 16,441   154,958   30,605  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.